{
  "docId": "019dd923-5e88-73ef-bd5c-fd5012384ae3",
  "docSlug": "bf350dd574c19997",
  "documentTitle": "2021 Air Street Capital The State of AI Report 2021",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 94,
  "pageCount": 188,
  "prevPage": 93,
  "nextPage": 95,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a combination of process flow diagrams and Kaplan-Meier survival curves to validate the efficacy of the AI platform.",
  "elementsJson": [
    "paragraph",
    "process_diagram",
    "line_chart",
    "big_number",
    "logo_grid"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5c-fd5012384ae3/94",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5c-fd5012384ae3#slide-94",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "In a prospective clinical trial of 56 blood cancer patients (right figure), those patients who received AI-guided therapy achieved a 55% overall response rate and a statistically significant improvement in progression-free survival over their respective prior line of therapy.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a209-58ae5c04bf09",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.48,
        "x": 0.48,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Kaplan-Meier survival curves comparing AI-matched treatment vs other treatments",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2d62c79c-e723-4faf-8631-71058085ad9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "diagram",
      "text": "Allcyte AI process flow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bb26a0c-1c62-49d9-afb4-17935286c85e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.05,
        "x": 0.47,
        "y": 0.65
      },
      "kind": "metric",
      "text": "55% ORR",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4eb54f3-b25e-42f1-b944-5f8c976b9e11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Overall Response Rate: 55%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a209-5daf45b4d687",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Drug selection for cancer patients is highly inefficient: over 90% of patients do not respond to the therapy that is selected by their oncologist. Why? Selection methods such as mutation sequencing are too reductionist. By contrast, Allcyte's AI (left figure) finds the most potent drug for a given patient. AI-based microscopy is used to measure how live cancer cells respond to 140 clinically-approved third-party anticancer drugs at the single cell level. In a prospective clinical trial of 56 blood cancer patients (right figure), those patients who received AI-guided therapy achieved a 55% overall response rate and a statistically significant improvement in progression-free survival over their respective prior line of therapy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7670abd8-cd70-4827-8d28-7305ab40991a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "Computer vision identifies the most potent drug for each cancer patient to improve survival",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "307d6e74-7e80-4cb9-bcb4-9a9f4d6d1426",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 152,
      "from": 5,
      "beatId": "019dd95a-0682-776c-8e35-0affbadec38e",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Definitions p.5-6, Exec Summary p.7, then Sections 1-3 catalog evidence.",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 152,
      "from": 10,
      "beatId": "019dd95a-0682-776c-8e35-1b3ee3a1c012",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Rising Action",
      "beatSlug": "mountain-rising-action",
      "evidence": "Three sections accumulating evidence of accelerating progress.",
      "position": 2,
      "confidence": 55,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 97,
      "from": 93,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3d-6d94b8e8790f",
      "evidence": "Multiple case studies validating the 2020 IPO prediction with applied biology proof.",
      "position": 12,
      "objective": "Show AI delivering in drug discovery",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 78,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}